Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls.

[1]  J. Mclaughlin,et al.  Cutaneous warts. , 2011, The Journal of hand surgery.

[2]  M. Pawlita,et al.  Helicobacter pylori Multiplex Serology , 2009, Helicobacter.

[3]  M. Pawlita,et al.  Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. , 2009, The Journal of general virology.

[4]  Y. Jacob,et al.  The EVER Proteins as a Natural Barrier against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections , 2009, Microbiology and Molecular Biology Reviews.

[5]  M. Pawlita,et al.  High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. , 2009, The Journal of investigative dermatology.

[6]  H. Pfister,et al.  Intrafamilial Transmission and Family-Specific Spectra of Cutaneous Betapapillomaviruses , 2008, Journal of Virology.

[7]  M. Pawlita,et al.  Seroprevalence of 34 Human Papillomavirus Types in the German General Population , 2008, PLoS pathogens.

[8]  M. Karagas,et al.  Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: A case‐control study , 2008, International journal of cancer.

[9]  G. Cappellano,et al.  Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. , 2008, The Journal of investigative dermatology.

[10]  Y. Jacob,et al.  Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses , 2007, The Journal of experimental medicine.

[11]  T. Key,et al.  A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition , 2007, International journal of cancer.

[12]  O. Forslund.  Genetic diversity of cutaneous human papillomaviruses. , 2007, The Journal of general virology.

[13]  A. Andersen,et al.  Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples , 2007, International journal of cancer.

[14]  R. DeSalle,et al.  Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. , 2007, Virology.

[15]  G. Orth.  Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. , 2006, Seminars in immunology.

[16]  M. Pawlita,et al.  E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients , 2006, The British journal of dermatology.

[17]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[18]  Y. Jacob,et al.  Cottontail Rabbit Papillomavirus E8 Protein Is Essential for Wart Formation and Provides New Insights into Viral Pathogenesis , 2006, Journal of Virology.

[19]  M. Karagas,et al.  Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. , 2006, Journal of the National Cancer Institute.

[20]  M. Pawlita,et al.  Suppression of non-specific binding in serological Luminex assays. , 2006, Journal of immunological methods.

[21]  U. Dianzani,et al.  CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. , 2005, Archives of dermatology.

[22]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[23]  J. McGregor,et al.  Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. , 2005, The Journal of investigative dermatology.

[24]  C. Proby,et al.  Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. , 2005, The Journal of investigative dermatology.

[25]  H. Hausen,et al.  Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1 , 1978, Medical Microbiology and Immunology.

[26]  Claude Fauquet,et al.  Classification of papillomaviruses. , 2004, Virology.

[27]  A. Griffith,et al.  Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. , 2003, Genomics.

[28]  S. Heller,et al.  TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins , 2003, BMC Genomics.

[29]  H. Pfister.  Chapter 8: Human papillomavirus and skin cancer. , 2003, Journal of the National Cancer Institute. Monographs.

[30]  N. Ramoz,et al.  Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis , 2002, Nature Genetics.

[31]  M. Pawlita,et al.  HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. , 2002, Journal of virological methods.

[32]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[33]  J. Sundberg,et al.  Human papillomavirus and skin cancer. , 2001, The journal of investigative dermatology. Symposium proceedings.

[34]  M. Pawlita,et al.  A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. , 2001, Journal of immunological methods.

[35]  N. Ramoz,et al.  Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. , 2000, The Journal of investigative dermatology.

[36]  J. Dillner.  The serological response to papillomaviruses. , 1999, Seminars in cancer biology.

[37]  N. Ramoz,et al.  A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. , 1999, The Journal of investigative dermatology.

[38]  J. Bouwes Bavinck,et al.  Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. , 1998, The Journal of investigative dermatology.

[39]  G. Orth,et al.  A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. , 1998, The Journal of investigative dermatology.

[40]  G. Orth,et al.  Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. , 1998, The Journal of investigative dermatology.

[41]  S. Jabłońska,et al.  Human papillomavirus-associated tumors of the skin and mucosa. , 1997, Journal of the American Academy of Dermatology.

[42]  G. Orth,et al.  Anogenital warts in children. , 1997, Clinics in dermatology.

[43]  Z. H. Hafeez,et al.  Epidermodysplasia verruciformis. , 1996, JPMA. The Journal of the Pakistan Medical Association.

[44]  F. Stubenrauch,et al.  Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. , 1995, Virology.

[45]  K. D. Hepp.  Food consumption habits in Germany--the clinician's point of view. , 1995, Metabolism: clinical and experimental.

[46]  H. Heseker,et al.  An epidemiologic study of food consumption habits in Germany. , 1995, Metabolism: clinical and experimental.

[47]  H. Pfister,et al.  Prevalence of antibodies to human papillomavirus type 8 in human sera , 1990, Journal of virology.

[48]  M. Yutsudo,et al.  Human papillomavirus type 17 transcripts expressed in skin carcinoma tissue of a patient with epidermodysplasia verruciformis , 1987, International journal of cancer.

[49]  G. Orth,et al.  Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus? , 1979, The Journal of investigative dermatology.